Stay updated on ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.5.5 appears on the page, replacing the previous Revision: v3.5.4. This indicates a minor update to the page versioning or documentation without altering the study content.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page's revision tag was updated to v3.5.4, replacing v3.5.3 and signaling a newer release. This metadata update does not change the visible content or functionality of the page.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page’s displayed revision/version has been updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check80 days agoChange DetectedThe site revision label has been updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision: v3.4.3 updated from v3.4.2.SummaryDifference0.1%

Stay in the know with updates to ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page.